Dr. Antonarakis on the frequency of genetic testing for prostate cancer in urology clinics

Emmanuel S. Antonarakis, MD, discusses the frequency of genetic testing in urology clinics for the management of patients with prostate cancer. He is associate director for Translational Research at the University of Minnesota Medical School Masonic Cancer Center, as well as the Clark Endowed Professor of Medicine and director of Genitourinary Oncology in the Department of Medicine’s Division of Hematology, Oncology, and Transplantation.